The TLR7/8/9 Antagonist IMO-8503 Inhibits Cancer-Induced Cachexia.
Calore F, Londhe P, Fadda P, Nigita G, Casadei L, Marceca GP, Fassan M, Lovat F, Gasparini P, Rizzotto L, Zanesi N, Jackson D, Mehta S, Nana-Sinkam P, Sampath D, Pollock RE, Guttridge DC, Croce CM.
Calore F, et al. Among authors: jackson d.
Cancer Res. 2018 Dec 1;78(23):6680-6690. doi: 10.1158/0008-5472.CAN-17-3878. Epub 2018 Sep 12.
Cancer Res. 2018.
PMID: 30209066
Free PMC article.